|
Implantable cardioverter defibrillators have been
shown to be highly effective in the treatment of ventricular arrhythmias1-5. However, accompanying this extremely high sensitivity
(i.e., appropriate ventricular tachycardia diagnosis) is the inappropriate treatment of
supraventricular rhythms (i.e., atrial fibrillation, sinus tachycardia, etc.) which the
device misinterprets as ventricular tachycardia due to accompanying high ventricular rate.
The incidence of inappropriate therapies due to supraventricular tachycardia has been
reported in up to 25% of patients6-8. This undesirable
consequence not only has negative effects on patient comfort and psychological well-being,
but has the potential to be proarrhythmic by inducing ventricular tachycardia or
ventricular fibrillation.
Other criteria, in addition to ventricular rate, have been introduced to device
detection algorithms to help reduce the incidence of inappropriate therapies due to
supraventricular tachycardia and thereby increase specificity. One of these discriminators
is interval stability, which measures the variability of ventricular interval cycle
lengths. A common characteristic of atrial fibrillation is irregular ventricular intervals
while ventricular tachycardia typically exhibits very stable ventricular intervals.
Another discriminator algorithm is sudden onset, which measures the abruptness in the
onset of the fast ventricular rate. This algorithm is intended to differentiate between
the gradual onset of rate in sinus tachycardia and the abrupt onset of ventricular
tachycardia.
Another criterion which has been shown to be an effective discriminator between
ventricular tachycardia and supraventricular tachycardia is endocardial ventricular
morphology9-16. These morphology algorithms reported in
the literature are typically computationally intense since they compare a test QRS complex
to a reference (i.e., template) complex on a point-by-point basis. These algorithms
require unacceptably high current for use in an implantable cardioverter defibrillator.
The challenge for implantable defi-brillator manufacturers is to design a robust and
accurate morphology algorithm which can operate in real-time and within the current drain
limitations of the implantable defibrillator. Therefore, we evaluated the performance of
the morphology algorithm implemented in the Ventritex Contour MD / Angstrom MD implantable
defibrillators.
|